Enliven Therapeutics Inc.

19.98
0.12 (0.60%)
At close: Apr 03, 2025, 3:59 PM
20.03
0.25%
Pre-market: Apr 04, 2025, 08:53 AM EDT

Enliven Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017
124.12M 100.14M 75.54M 110.02M 130.37M 4.94M 7.38M 9.67M
189.32M 153.01M n/a 41.97M 40.52M 23.97M n/a n/a
n/a n/a 54K 175K 88K 88K n/a n/a
7.17M 4.65M 3.98M 1.53M -88K 2.14M n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
4.69M 13M 2.22M 646K 222K 1.72M 323K 552K
318.13M 266.15M 77.75M 110.67M 130.59M 30.62M 7.71M 10.22M
458K 1.06M 1.52M 954K 416K 442K n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
7.63M 5.72M 5.54M 2.66M 416K 2.67M n/a n/a
325.76M 271.87M 83.3M 113.33M 131M 33.3M 7.71M 10.22M
1.34M 532K 3.44M 2.52M 808K 1.66M 908K 431K
n/a n/a 5.51M 2.7M 429K n/a n/a n/a
n/a n/a n/a n/a n/a n/a n/a n/a
14.57M 21.7M 3.82M 233K 136K 1.74M 787K 196K
15.91M 25.89M 9.71M 5.75M 1.48M 4.2M 1.83M 826K
n/a n/a n/a n/a n/a n/a n/a 660K
n/a 67K 150.41M 150.46M 149.83M 184K 32.19M n/a
n/a 67K 150.41M 150.46M 149.83M 184K 32.19M 660K
15.91M 25.96M 160.12M 156.22M 151.31M 4.38M 1.83M 1.49M
n/a 335K 323K 159K 105K n/a n/a 660K
49K 41K 1K 1K 1K 4K 4K 4K
-243.47M -154.45M -82.86M -45.2M -20.46M -54.75M -31.29M -19.95M
55K 141K -149.75K -16K 4K 32K n/a n/a
309.85M 245.91M -76.83M -42.89M -20.3M -48.85M -26.32M -15.53M
189.32M 153.01M 54K 42.14M 40.61M 24.06M n/a n/a